Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001520138-24-000313
Filing Date
2024-09-24
Accepted
2024-09-24 16:46:59
Documents
16
Period of Report
2024-09-23
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT AMENDMENT NO.1 bivi-20240923_8ka.htm   iXBRL 8-K/A 31084
2 EXHIBIT 5.1 bivi-20240923_8kaex5z1.htm EX-5.1 21677
6 GRAPHIC image_001.jpg GRAPHIC 28491
7 GRAPHIC image_002.jpg GRAPHIC 16735
  Complete submission text file 0001520138-24-000313.txt   301188

Data Files

Seq Description Document Type Size
3 XBRL LABEL FILE bivi-20240923_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bivi-20240923_pre.xml EX-101.PRE 24173
5 XBRL SCHEMA FILE bivi-20240923.xsd EX-101.SCH 3027
18 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20240923_8ka_htm.xml XML 5005
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-39015 | Film No.: 241320649
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)